drugset / Trial / NCT01584713

Stromal Vascular Fraction (SVF) for Treatment of Enterocutaneous Fistula (HULPUTC)

NCT01584713

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine safety of Stromal Vascular Fraction (SVF) for the treatment of enterocutaneous fistula.

Timeline

Start
2011-12
Primary completion
2012-07
Completion
2013-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Rexlemestrocel-L Cell therapy Other

Indications